Rhl Group »

Immunitybio shares owned by Rhl Group

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Rhl Group from 13F filings

Historical chart of Rhl Group investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Rhl Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Rhl Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $72k 9.4k 7.67

More positions owned by Rhl Group

Global X 1-3 Month T-bill Etf Etf (CLIP)
Dimensional Core Fixed Income Etf Etf (DFCF)
Vanguard Long-term Corporate Bond Index Fund Etf (VCLT)
Capital Group U.s. Multi-sector Income Etf Etf (CGMS)
Proshares Ultrashort Qqq Etf (QID)
Devon Energy Corp Common Stock (DVN)
Occidental Pete Corp Common Stock (OXY)
Dte Energy Common Stock (DTE)
Merck & Co Common Stock (MRK)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Western Digital Corp Common Stock (WDC)
Palantir Technologies Inclass Class A Common Stock (PLTR)
Nvidia Corp Common Stock (NVDA)
Touchstone Ultra Short Income Etf Etf (TUSI)
Apple Common Stock (AAPL)

View all positions for Rhl Group

Top funds holding Immunitybio

Vanguard Group
BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
D. E. Shaw & Co
Geode Capital Management
Susquehanna International
Citadel Advisors
Two Sigma Investments
LMR Partners
Morgan Stanley
Hrt Financial
Woodline Partners
Goldman Sachs Group

View all funds holding Immunitybio